Dolichovespula maculata venom protein

Identification

Summary

Dolichovespula maculata venom protein is a venom protein produced by the bald-faced hornet used in allergy testing.

Generic Name
Dolichovespula maculata venom protein
DrugBank Accession Number
DB10958
Background

Dolichovespula maculata venom protein is an extract of Dolichovespula maculata venom. Dolichovespula maculata venom protein is used in allergenic testing.

Type
Biotech
Groups
Approved
Biologic Classification
Allergenics
Allergen Extract
Synonyms
  • bald-faced hornet venom protein
  • White faced hornet venom protein

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Brand Name Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
Hymenoptera Venom Product-white-faced Hornet Venom Protein (550 Mcg)Powder, for solution550 mcg / vialSubcutaneousJubilant Hollisterstier Llc1997-12-06Not applicableCanada flag
Pharmalgen White Faced Hornet VenomPowder, for solution120 mcg / vialIntradermal; SubcutaneousAlk Abelló A/S1994-12-312023-02-07Canada flag
Pharmalgen White Faced Hornet Venom ProteinPowder, for solution1.1 mg / vialIntradermal; SubcutaneousAlk Abelló A/S1996-09-302023-02-07Canada flag
Venomil Inj 100mcg/ml White Faced HornetLiquid100 mcg / mLSubcutaneousHollister Stier, Unit Pharm, Division Of Miles Canada Inc.1983-12-311998-09-25Canada flag
Venomil Inj 10mcg/ml White Faced HornetLiquid10 mcg / mLSubcutaneousHollister Stier, Unit Pharm, Division Of Miles Canada Inc.1983-12-311998-09-25Canada flag
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Hymenoptera Venom DiagnosticDolichovespula maculata venom protein (120 ug/1) + Apis mellifera venom (120 ug/1) + Dolichovespula arenaria venom protein (120 ug/1) + Polistes fuscatus venom protein (120 ug/1) + Vespula maculifrons venom protein (120 ug/1)KitSubcutaneousALK-Abello A S1992-11-202010-04-09US flag
Hymenoptera Venom Product-mixed Vespid Venom Protein (1650 Mcg)Dolichovespula maculata venom protein (550 mcg / vial) + Dolichovespula arenaria venom protein (550 mcg / vial) + Vespula vulgaris venom protein (550 mcg / vial)Powder, for solutionSubcutaneousJubilant Hollisterstier Llc1997-12-16Not applicableCanada flag
Mixed Vespid Hymenoptera Venom MultidoseDolichovespula maculata venom protein (100 ug/1mL) + Dolichovespula arenaria venom protein (100 ug/1mL) + Vespula germanica venom protein (20 ug/1mL) + Vespula maculifrons venom protein (20 ug/1mL) + Vespula pensylvanica venom protein (20 ug/1mL) + Vespula squamosa venom protein (20 ug/1mL) + Vespula vulgaris venom protein (20 ug/1mL)Injection, powder, lyophilized, for solutionSubcutaneousJubilant Hollisterstier Llc1995-04-11Not applicableUS flag
Mixed Vespid Hymenoptera Venom MultidoseDolichovespula maculata venom protein (100 ug/1mL) + Dolichovespula arenaria venom protein (100 ug/1mL) + Vespula germanica venom protein (20 ug/1mL) + Vespula maculifrons venom protein (20 ug/1mL) + Vespula pensylvanica venom protein (20 ug/1mL) + Vespula squamosa venom protein (20 ug/1mL) + Vespula vulgaris venom protein (20 ug/1mL)Injection, powder, lyophilized, for solutionSubcutaneousJubilant Hollisterstier Llc1980-12-11Not applicableUS flag
Mixed Vespid Hymenoptera Venom Venomil MaintenanceDolichovespula maculata venom protein (100 ug/1mL) + Dolichovespula arenaria venom protein (100 ug/1mL) + Vespula germanica venom protein (20 ug/1mL) + Vespula maculifrons venom protein (20 ug/1mL) + Vespula pensylvanica venom protein (20 ug/1mL) + Vespula squamosa venom protein (20 ug/1mL) + Vespula vulgaris venom protein (20 ug/1mL)KitSubcutaneousJubilant Hollisterstier Llc1982-02-22Not applicableUS flag

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
J8DAZ3T66L
CAS number
Not Available

References

General References
Not Available
PubChem Substance
347911048
RxNav
1297525

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
KitSubcutaneous
Powder, for solutionSubcutaneous550 mcg / vial
Injection, powder, lyophilized, for solutionSubcutaneous
Powder, for solutionSubcutaneous
Powder, for solutionIntradermal; Subcutaneous
Powder, for solutionIntradermal; Subcutaneous120 mcg / vial
Powder, for solutionIntradermal; Subcutaneous1.1 mg / vial
LiquidSubcutaneous100 mcg / mL
LiquidSubcutaneous10 mcg / mL
LiquidSubcutaneous
Kit; powder, for solutionIntradermal
Injection, powder, lyophilized, for solutionPercutaneous; Subcutaneous100 ug/1mL
KitIntradermal; Percutaneous100 ug/1mL
KitSubcutaneous100 ug/1mL
Injection, powder, lyophilized, for solutionSubcutaneous100 ug/1mL
Powder, for solutionIntradermal; Subcutaneous500 mcg / vial
Powder, for solutionSubcutaneous1300 mcg / vial
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created at December 01, 2015 20:04 / Updated at March 18, 2024 16:48